Blood cancer patients may get transfusions at home in hospice trial

NCT ID NCT06487247

Recruiting now Symptom relief Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a new program that gives blood cancer patients access to blood transfusions at home while they receive hospice care. The goal is to see if this improves their quality of life, mood, and reduces hospital visits near the end of life. The trial will include 700 adults with relapsed or refractory blood cancers who are receiving care at Dana-Farber Cancer Institute.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HEME-Hospice program (home blood transfusions combined with hospice care)
What this could lead to: If it works, this could offer blood cancer patients a way to receive comforting transfusions at home while in hospice, potentially improving their quality of life and mood at the end of life.
What could go wrong: This is a behavioral intervention study, not a drug trial, so it won't cure the cancer. The benefit may be modest, and results may not apply to all hospice settings or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematologic disorder hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm leukemia lymphoma myelodysplastic syndrome Myelodysplastic Syndromes plasma cell myeloma plasma cell neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOLOGIC DISEASES HEMATOLOGIC MALIGNANCY LEUKEMIA LYMPHOMA MYELODYSPLASTIC SYNDROMES MYELOMA

Contacts and locations

Locations

Brigham and Women's Hospital
RECRUITING

Boston, Massachusetts, 02215, United States
Dana-Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.